Fate Therapeutics, Inc. (FATE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 5.27 |
| Open | 5.27 |
| Bid | 5.03 x 400 |
| Ask | 5.05 x 100 |
| Day's range | 4.98 - 5.34 |
| 52-week range | 1.63 - 8.83 |
| Volume | |
| Avg. volume | 2,800,830 |
| Market cap | 573.466M |
| Beta (5Y monthly) | 1.68 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Fate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress
Fate Therapeutics (FATE) gains 86.4% on encouraging pipeline progress of its cellular immunotherapies for cancer.
- Zacks
Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?
Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Why Is Myriad (MYGN) Down 1% Since Last Earnings Report?
Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.